532612 Stock Overview
Manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Indoco Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹305.35 |
| 52 Week High | ₹416.95 |
| 52 Week Low | ₹286.50 |
| Beta | 0.44 |
| 11 Month Change | 0.98% |
| 3 Month Change | -16.46% |
| 1 Year Change | -16.32% |
| 33 Year Change | -19.76% |
| 5 Year Change | 86.87% |
| Change since IPO | 478.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532612 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.3% | 1.1% | 2.0% |
| 1Y | -16.3% | 43.3% | 28.6% |
Return vs Industry: 532612 underperformed the Indian Pharmaceuticals industry which returned 43.3% over the past year.
Return vs Market: 532612 underperformed the Indian Market which returned 28.6% over the past year.
Price Volatility
| 532612 volatility | |
|---|---|
| 532612 Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532612 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532612's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 6,000 | Sundeep Bambolkar | www.indoco.com |
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations.
Indoco Remedies Limited Fundamentals Summary
| 532612 fundamental statistics | |
|---|---|
| Market cap | ₹29.08b |
| Earnings (TTM) | ₹320.60m |
| Revenue (TTM) | ₹17.73b |
87.9x
P/E Ratio1.6x
P/S RatioIs 532612 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532612 income statement (TTM) | |
|---|---|
| Revenue | ₹17.73b |
| Cost of Revenue | ₹6.23b |
| Gross Profit | ₹11.51b |
| Other Expenses | ₹11.18b |
| Earnings | ₹320.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.48 |
| Gross Margin | 64.88% |
| Net Profit Margin | 1.81% |
| Debt/Equity Ratio | 75.2% |
How did 532612 perform over the long term?
See historical performance and comparison